Some of Thursday's midday movers:» Read More
Here's why you should keep a close eye on these six stocks.
Just when you thought it was safe to go into the water – new signs are emerging that turmoil may lurk just below the surface.
What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.
Gold rose to session highs near $1,260 an ounce on Tuesday. Is this a good time for investors to get into the commodity? Patrick Cunningham, managing director at Manning & Napier discussed his best plays.
The correlation of S&P 500 members to daily move in the benchmark overall has been steadily rising toward parity over the last 10 years, a sign that exchange-traded funds, electronic trading and a short-term mentality is slowly killing individual stock picking based on fundamentals.
The Lightning Round is extended in this CNBC.com exclusive feature.
As investors brace for what could be another roller coaster ride for the stock market this summer, CNBC.com conducted a stock screen of the S&P 500 index, searching for the top ten percentage gainers in the past ten years.
With the government expected to spend $19 billion upgrading medical records, is Allscripts a can’t lose trade? Hear from the CEO!
There’s still a week-and-a-half left in the month, but the markets are currently maintaining yet another month of gains.
Cramer makes the call on viewers' favorite stocks.
Dell's acquisition of Perot Systems may be the beginning of a larger shopping spree. Bernstein analyst Toni Sacconaghi reveals his list of potential takeover targets.
When it rains, it pours. I mean, what a crazy Monday for deals and data in biopharma.
As the health care debate continues, Todd Weller, health care IT analyst at Stifel Nicolaus, and Les Funtleyder, health care strategist at Miller Tabak, zero in on health care names that may bring healthy returns.
Expect the Fed to continue their purchase of Treasuries, agency debt, and mortgage-backed securities and most feel the Fed will leave the purchase programs as is and not expand the programs.
Approaching the close, the Dow has cut its losses almost in half...the five financial-oriented stocks in the Dow (B of A, Travelers, JP Morgan, AmEx, and our parent General Electric) are responsible for a negative 40 points in the Dow; but with the exception of some weakness in energy (Chevron, ExxonMobil), most other sectors are flat to down 1 percent.
President Obama probably won’t find a better way to reduce wasteful medical spending.
Opposition to the Obama administration's health care plan had a new voice Monday, as the U.S. Chamber of Commerce launched a critical ad campaign suggesting alternatives. But John Sullivan of Leerink Swann says this is a great time to buy health stocks.
The Dow Industrials briefly turned positive for the year earlier this morning. WAHOO! But wait…the S&P 500 turned positive for 2009 nearly one month ago and is now up over 4.5% this year. So why the performance lag in the Dow (compared to the S&P)?
The federal stimulus package passed in February may help some IT companies climb the stock charts. The law provides $19 billion to replace the ubiquitous paper chart on a clipboard with electronic medical records.
This year, more than any other, it looks as if the intersection between Wall Street and Main Street lies in the heart of Washington DC.